Rubin Eyal 4
4 · Protalix BioTherapeutics, Inc. · Filed Aug 17, 2023
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Common Stock
2023-08-15+201,903→ 570,000 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended. The shares vest over a three-year period beginning on the date of grant in 12 equal increments on each quarterly anniversary of the date of grant. The restricted shares are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Plan.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.